Mini Gastric Bypass vs GLP-1 Medications
A neutral educational comparison of Mini Gastric Bypass (OAGB) surgery and GLP-1 receptor agonist therapy. Both are tools for weight and metabolic management. Neither is right for every patient.
How They Work
GLP-1 receptor agonists are injectable medications that work through hormonal pathways affecting appetite, satiety, and glucose handling. Examples include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).
Mini Gastric Bypass (OAGB) is a laparoscopic procedure that creates a long gastric pouch with a single anastomosis to a loop of small intestine. It combines restrictive and metabolic mechanisms through an anatomical change.
Duration Of Use
GLP-1 medications generally require ongoing use to maintain effect. Discontinuation has been associated in published studies with weight regain in many patients. Mini Gastric Bypass creates a long-term anatomical change supporting weight and metabolic management without ongoing weekly medication.
Reversibility & Permanence
GLP-1 therapy is non-anatomical and can be stopped under clinician supervision. Mini Gastric Bypass is considered a long-term anatomical modification; revision or reversal is possible in specific situations but is not routine.
Side Effects & Risks
GLP-1 medications can cause nausea, gastrointestinal symptoms, and other side effects, and have specific clinical considerations. Mini Gastric Bypass carries surgical risks including bleeding, infection, leak, ulcers, bile reflux, internal hernia, and long-term nutritional considerations. Both options require ongoing clinical follow-up.
Cost & Access
GLP-1 medication cost and insurance access vary widely by region and plan. Bariatric surgery cost varies by program, insurance coverage, and geography. Patients researching either pathway should review long-term cost as part of decision-making.
Combined Approaches
Some patients and clinical teams use GLP-1 therapy as part of pre-operative optimization or in sequence with bariatric surgery. These pathways are individualized and require coordination among the prescribing clinician, surgical team, and patient.
Important Notes
This page does not advise starting, stopping, or changing any medication. It does not claim one pathway is superior to the other. Treatment decisions must be made with qualified clinicians who know your individual medical history.